Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
Recruiting · Locations being confirmed
Always free
Study care at no cost to you
For your time and travel
Many studies pay you back
Most need no insurance or papers
Legal status usually isn't required; we'll tell you each study's requirements
Interpreters available
Ask for your language
Your choice
Voluntary — you can stop anytime
What is this study?
This study is assess the safety and performance of the Neurotronic Infusion catheter for treatment of patients with Type 2 Diabetes (T2DM) and hypertension.
It is , overseen by an independent and licensed medical staff.
Read the full clinical description
This study is assess the safety and performance of the Neurotronic Infusion catheter for treatment of patients with Type 2 Diabetes (T2DM) and hypertension.
Who this study is looking for
In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.
✅ You may be able to join if…
- •Age 21 to 65.
- •Have type 2 diabetes with specific lab results (fasting plasma glucose, HbA1c, triglycerides) and take metformin (with or without another diabetes pill).
- •Have type 2 diabetes for 10 years or less (based on how long you’ve had it).
- •Have high blood pressure with specific blood pressure readings and take up to 3 blood pressure medicines.
- •Have a BMI between 27.5 and 40, and meet artery size/length needs for treatment (kidney and/or liver arteries).
🚫 You may not be able to join if…
- •Have type 1 diabetes, or type 2 diabetes that is poorly controlled (HbA1c over 9.0% or using insulin).
- •Have blood pressure that’s too low (office diastolic less than 90 mmHg).
- •Take more than 3 blood pressure medications, or take beta blockers.
- •Had high blood sugar episodes that required hospital care in the 180 days before screening.
- •Have certain serious eye/nerve problems (proliferative retinopathy or peripheral neuropathy), or cannot safely receive the kidney/liver artery catheter treatment (based on study doctor’s assessment).
Are you a good fit?
Simplified highlights. The study team always confirms the full details with you.
- ✓Adults roughly 21–65
- ✓A BMI around 27.5 or higher
- ✓Have Obesity / overweight or Type 2 diabetes or High blood pressure
- !Some conditions may not be a fit: Heart / cardiovascular disease, Kidney disease, COPD (chronic lung disease)
- !Not for people who are pregnant or breastfeeding
What to expect, step by step
- 1
Usually a few weeks
The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.
- 2
Treatment
If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.
- 3
Follow-up
After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.
Has this treatment been tested before?
This is an early-stage study. The treatment has gone through laboratory and preliminary testing before being studied in people here.
What you need to know before you apply
What is this study testing?+
This study is assess the safety and performance of the Neurotronic Infusion catheter for treatment of patients with Type 2 Diabetes (T2DM) and hypertension.
Is it safe? Who makes sure of that?+
This is an early study (Phase 1), focused mostly on safety. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.
Will I get a placebo instead of the real treatment?+
Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.
Do I have to stop taking my current medications?+
It depends on the study. Some let you stay on your current medications and some ask you to adjust them. Never stop a medication on your own — the study team will review everything with you first.
Does it cost anything? Will I be paid?+
Study-related care is provided at no cost to you. This study may also compensate you for your time and travel — the team will tell you the amount before you join. You should never be asked to pay to take part.
Do I need insurance? Will anyone ask about my immigration status?+
No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.
What if English isn't my first language?+
You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.
Is my information private?+
Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.
Some requirements (like specific lab values or timing) are confirmed directly by the study team, not by us.
Source: ClinicalTrials.gov · NCT05363761 · Locations: being confirmed